tiprankstipranks
Trending News
More News >
VitaSpring Biomedical (VSBC)
OTHER OTC:VSBC
US Market

VitaSpring Biomedical (VSBC) Cash flow

Compare
3 Followers

VitaSpring Biomedical Cash Flow

VSBC's free cash flow for Q3 2024 was $0.00. For the 2024 fiscal year, VSBC's free cash flow was decreased by $-11.81K and operating cash flow was $0.00. See a summary of the company’s cash flow.
Cash Flow
Mar 23Mar 22Mar 21Mar 20Mar 19
Operating Cash Flow
$ 0.00$ 84.81K$ -42.13K$ -105.00$ -34.25K
Investing Cash Flow
$ 0.00$ -73.00K$ 0.00$ 0.00$ 0.00
Financing Cash Flow
$ 0.00$ 50.00K$ 87.53K$ 0.00$ 29.15K
End Cash Position
$ 107.21K$ 107.21K$ 45.40K$ 0.00$ 105.00
Free Cash Flow
$ 0.00$ 11.81K$ -42.13K$ -105.00$ -34.25K
Currency in USD

VitaSpring Biomedical Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis